Company: NDRA
Filing Date: 2025-10-30
Form Type: 424B5
Source: 0001213900-25-103705
Chunk: 54

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-10-30
Form: 424B5
Chunk 54
---
 series of debt securities or the method by which such dates will be determined, the terms of any 
 deferral of interest and any right of ours to extend the interest payment periods;                                                  |

| ● | the place or places where the principal and interest on the series of debt securities will be payable; |

| ● | the terms and conditions upon which debt securities of the series may be redeemed, in whole or in part, at our option or otherwise; |

<div align='center'>11</div>

| ● | our obligation, if any, to redeem, purchase, or repay debt securities of the series pursuant to any sinking fund or other specified 
 event or at the option of the holders and the terms of any such redemption, purchase, or repayment;                                 |

| ● | the terms, if any, upon which the debt securities of the series may be convertible into or exchanged for other securities, including, 
 among other things, the initial conversion or exchange price or rate and the conversion or exchange period;                           |

| ● | if the amount of principal, premium, if any, or interest with respect to the debt securities of the series may be determined with 
 reference to an index or formula, the manner in which such amounts will be determined;                                            |

| ● | if any payments on the debt securities of the series are to be made in a currency or currencies (or by reference to an index or formula) 
 other than that in which such securities are denominated or designated to be payable, the currency or currencies (or index or formula)   
 in which such payments are to be made and the terms and conditions of such payments;                                                     |

| ● | any changes or additions to the provisions of the indenture dealing with defeasance, including any additional covenants that may be 
 subject to our covenant defeasance option;                                                                                          |

| ● | the currency or currencies in which payment of the principal and premium, if any, and interest with respect to debt securities of        
 the series will be payable, or in which the debt securities of the series shall be denominated, and the particular provisions applicable 
 thereto in accordance with the indenture;                                                                                                |

| ● | the portion of the principal amount of debt securities of the series which will be payable upon declaration of acceleration or provable 
 in bankruptcy or the method by which such portion or amount shall be determined;                                                        |

| ● | whether the debt securities of the series will be secured or guaranteed and, if so, on what terms; |

| ● |